Completed PHASE2 INTERVENTIONAL 2-arm NCT01329796

Pertubation With Lignocaine in Endometriosis (PLEASE)

Pertubation With Lignocaine in Endometriosis Associated Symptoms Effect Study

Sponsor: Isifer AB

Interventions Lignocaine Ringers Solution

Updated 6 times since 2017 Last updated: Apr 5, 2011 Started: Mar 31, 2007 Primary completion: Jun 30, 2009 Completion: Mar 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Dysmenorrhea and Endometriosis, this trial is completed. The trial is conducted by Isifer AB and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Oct 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Oct 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Mar 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Isifer AB
Region Stockholm

Data source: Isifer AB

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stockholm, Sweden